» Articles » PMID: 7870176

An HMG-box-containing T-cell Factor Required for Thymocyte Differentiation

Overview
Journal Nature
Specialty Science
Date 1995 Mar 2
PMID 7870176
Citations 204
Authors
Affiliations
Soon will be listed here.
Abstract

Two candidate genes for controlling thymocyte differentiation, T-cell factor-1 (Tcf-1) and lymphoid enhancer-binding factor (Lef-1), encode closely related DNA-binding HMG-box proteins. Their expression pattern is complex and largely overlapping during embryogenesis, yet restricted to lymphocytes postnatally. Here we generate two independent germline mutations in Tcf-1 and find that thymocyte development in (otherwise normal) mutant mice is blocked at the transition from the CD8+, immature single-positive to the CD4+/CD8+ double-positive stage. In contrast to wild-type mice, most of the immature single-positive cells in the mutants are not in the cell cycle and the number of immunocompetent T cells in peripheral lymphoid organs is reduced. We conclude that Tcf-1 controls an essential step in thymocyte differentiation.

Citing Articles

TCF1 dosage determines cell fate during T cell development.

Verma A, Aylward B, Ma F, Sherman C, Chopp L, Shinton S Sci Adv. 2024; 10(48):eado5982.

PMID: 39602533 PMC: 11601199. DOI: 10.1126/sciadv.ado5982.


Transcription factor TCF1 binds to RORγt and orchestrates a regulatory network that determines homeostatic Th17 cell state.

Mangani D, Subramanian A, Huang L, Cheng H, Krovi S, Wu Y Immunity. 2024; 57(11):2565-2582.e6.

PMID: 39447575 PMC: 11614491. DOI: 10.1016/j.immuni.2024.09.017.


Intrinsically disordered domain of transcription factor TCF-1 is required for T cell developmental fidelity.

Goldman N, Chandra A, Johnson I, Sullivan M, Patil A, Vanderbeck A Nat Immunol. 2023; 24(10):1698-1710.

PMID: 37592014 PMC: 10919931. DOI: 10.1038/s41590-023-01599-7.


Dissecting the regulatory network of transcription factors in T cell phenotype/functioning during GVHD and GVT.

Harris R, Karimi M Front Immunol. 2023; 14:1194984.

PMID: 37441063 PMC: 10333690. DOI: 10.3389/fimmu.2023.1194984.


Exhausted T cells hijacking the cancer-immunity cycle: Assets and liabilities.

Brunell A, Lahesmaa R, Autio A, Thotakura A Front Immunol. 2023; 14:1151632.

PMID: 37122741 PMC: 10140554. DOI: 10.3389/fimmu.2023.1151632.